LoadingLoadingLoading29 funds hold it.Insiders net selling.
Net selling: insiders sold $95.6M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.61 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 27, 2026
EPS expected
$0.56 to $0.69
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $0.59 / $0.61Yahoo Finance | -4.07% miss | $212.8M No estimate | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $0.45 / $0.40Yahoo Finance | +13.29% beat | $182.3M No estimate | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $0.49 / $0.43Yahoo Finance | +15.15% beat | $170.7M No estimate | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | $0.44 / $0.24Yahoo Finance | +81.62% beat | $154.2M No estimate | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $0.70 / $0.09Alpha Vantage | +$0.61 beat | $139.1M No estimate | Unavailable |
| Mar 31, 2025 | May 5, 2025 | Unavailable | - | $123.8M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $154.2M | $170.7M | $182.3M | $212.8M |
| Cost of what it sold | $28.0M | $26.6M | $28.1M | $28.9M |
| Gross profit | $126.2M | $144.2M | $154.2M | $183.9M |
| What it spent | ||||
| Research and development | $31.9M | $32.8M | $30.3M | $34.1M |
| Sales and admin | $36.9M | $24.4M | $23.0M | $28.0M |
| Other operating costs | $63.6M | $59.8M | $68.8M | $81.4M |
| Total operating expenses | $132.3M | $116.9M | $122.2M | $143.5M |
| What was left | ||||
| Operating profit | -$6.1M | $27.3M | $32.1M | $40.4M |
| Profit before tax | -$1.6M | $32.2M | $35.9M | $44.4M |
| Tax | $206.0K | $122.0K | $814.0K | $740.0K |
| Net profit | -$1.8M | $32.1M | $35.1M | $43.7M |
| EBITDA | -$4.8M | $29.7M | $33.2M | $45.5M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bearish
A 10% stockholder proposes selling Hinge Health (NYSE: HNGE) shares through Raymond James.
NeutralOct 15Insight Venture Partners X (Co-Investors) Files Form 144 for Proposed Sale of 17,825 Hinge Health Shares
Leans bearishOct 15Hinge Health exec. chairman Gabriel Mecklenburg sells $20.6m in stock
NeutralOct 15A 10% stockholder proposes another Hinge Health (HNGE) share sale after selling shares October 9.
NeutralOct 14After a $3.38M sale, a 10% stockholder proposes another at Hinge Health (HNGE).
NeutralOct 14Hinge Health exec. chairman Gabriel Mecklenburg sells $20.6m in stock
NeutralOct 14Hinge Health exec. chairman Gabriel Mecklenburg sells $20.6m in stock By Investing.com
Leans bearishOct 14Form 4 Hinge Health Inc: Gabriel M.I. Mecklenburg (Director, Exec. Chairman & Co-Founder) For: 12 October
NeutralOct 14
